Resonetics to Strengthen Medical Device Offerings
Resonetics has taken a significant step forward by signing an agreement to acquire Resolution Medical, a renowned innovator in the design and manufacturing of complex medical devices. This acquisition aims to broaden Resonetics' capabilities in two critical therapeutic markets: neuromodulation and structural heart technologies. Based in Fridley, MN, Resolution Medical also operates in the Netherlands and is currently under the management of Arcline Investment Management.
Enhancing Service Capabilities in Growing Markets
The integration of Resolution Medical into Resonetics is set to create a powerhouse of complementary capabilities. This strategic move is expected to provide Resonetics with enhanced tools to better serve the rapidly growing segments of neuromodulation, structural heart, and interventional cardiology. Once completed in 2026, following regulatory approvals, this acquisition will profoundly impact how these markets are served.
Leadership Insights and Future Vision
Kevin Kelly, the CEO of Resonetics, expressed enthusiasm about the acquisition, stating, "Resolution Medical is an exceptional organization with deep technical expertise and a commitment to innovation. This acquisition will elevate our ability to provide customers with integrated solutions that are essential in today’s fast-paced medical device industry." This sentiment resonates across both companies, indicating a strong alignment toward customer-centric service in high-growth areas.
The Value Proposition for Customers and Employees
Peter Herman, CEO of Resolution Medical, emphasized the mutual benefits of this partnership, saying, "Our customers will gain access to a wider array of capabilities through an integrated partnership. At the same time, our employees will enjoy the advantage of being part of a larger organization, which will allow us to improve the scale and quality of the solutions we deliver." This foresight presents a promising future for all stakeholders.
The Strength of Resolution Medical’s Workforce
Resolution Medical is known for its highly skilled workforce, comprising over 240 employees, including more than 100 engineers. With a solid reputation for high-quality design engineering and cleanroom production, the company has excelled in developing medical devices categorized as Class II and III, fostering robust relationships with various customers in the healthcare sector. As the demand for innovative medical solutions continues to rise, this acquisition is well-timed.
Expanding Product Lifecycle Support
Supported by prominent investment firms Carlyle and GTCR, Resonetics not only focuses on product development but also excels in providing comprehensive manufacturing solutions that span from initial prototyping to high-volume production. The addition of Resolution Medical enhances these capabilities, allowing Resonetics to cater effectively to the increasing complexity of medical devices throughout the entire product lifecycle.
A Continued Commitment During Transition
In the interim before the acquisition finalizes, both Resonetics and Resolution Medical will continue their operations independently. According to legal advisors to Resonetics, they will ensure that the transition occurs smoothly, without disruption to existing operations and commitments to customers.
About Resonetics
Founded in 1987, Resonetics is a trailblazer in advanced engineering and manufacturing solutions for the medical device industry. The company holds a prominent position in laser processing, nitinol manufacturing, and photochemical machining, among other services. With a firm commitment to quality and customer satisfaction, Resonetics operates multiple state-of-the-art facilities and is ISO 13485:2016 certified, highlighting its dedication to excellence in the field.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm that employs a diversified strategy across various sectors, aiming to generate transformative growth in its portfolio companies. With a robust financial foundation and a commitment to innovation, Carlyle strategically partners with management teams to build leading businesses worldwide.
Frequently Asked Questions
What is the purpose of Resonetics acquiring Resolution Medical?
The acquisition aims to enhance Resonetics' capabilities in neuromodulation and structural heart markets, providing fully integrated solutions.
How many employees does Resolution Medical have?
Resolution Medical employs over 240 individuals, including more than 100 engineers, showcasing their technical expertise.
When is the acquisition expected to close?
The acquisition is anticipated to close in 2026, contingent on necessary regulatory approvals.
What sectors does Carlyle invest in?
Carlyle invests across various sectors, including healthcare, technology, and consumer services, aiming for transformative growth.
Will both companies continue operating independently until the acquisition closes?
Yes, both Resonetics and Resolution Medical will maintain their operations independently until the transaction is finalized.
